Polyamide 11 & 12 Market in 3D Printing 2016 - Global Forecast to 2020
Feb 26, 2016 09:02 am UTC| Business
Dublin, Feb. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/9vpftq/polyamide_11_and) has announced the addition of the "Polyamide 11 12 Market in 3D Printing by Polyamide Type...
Dassault Aviation: 2015 consolidated net sales
Feb 26, 2016 07:41 am UTC| Business
SAINT-CLOUD CEDEX 300, France, Feb. 26, 2016 -- 2015 consolidated net sales amounted to EUR 4,176 million, compared to EUR 3,680 million in 2014. Next financial information The DASSAULT AVIATION Group will release...
Feb 26, 2016 07:29 am UTC| Business
AMSTERDAM, Netherlands, Feb. 26, 2016 -- ING confirms that the Netherlands is its Home Member State. This is a mandatory announcement to comply with the changes made to the Dutch Financial Supervision Act, section...
GLOBAL INFRASTRUCTURE PARTNERS ANNOUNCES THE SALE OF LONDON CITY AIRPORT
Feb 26, 2016 07:00 am UTC| Business
NEW YORK and LONDON, Feb. 26, 2016 -- Global Infrastructure Partners (GIP), a leading independent infrastructure investor, announced today that its Fund, Global Infrastructure Partners I, has agreed to sell its 75%...
Koninklijke Ten Cate NV : TenCate records 5% organic revenue growth in 2015
Feb 26, 2016 06:35 am UTC| Business
Organic revenue growth of 5% for the full year 2015 Growth of military protective fabrics, synthetic turf systems and components, and composites EBITA* € 68.3 million (2014: € 53.3 million); EBITA...
Marine Harvest ASA (OSE: MHG, NYSE: MHG): Ex-dividend NOK 1.40 today
Feb 26, 2016 06:14 am UTC| Business
BERGEN, Norway, Feb. 26, 2016 -- The shares in Marine Harvest ASA will be traded ex-dividend NOK 1.40 as from today 26 February 2016. This information is subject to the disclosure requirements pursuant to section 5-12...
Immunomedics Announces Termination of Epratuzumab Licensing Agreement With UCB
Feb 26, 2016 06:00 am UTC| Business
MORRIS PLAINS, N.J., Feb. 26, 2016 -- Immunomedics, Inc., (Nasdaq:IMMU) today announced receipt of a notice from UCB terminating the May 2006 Development, Collaboration and License Agreement for epratuzumab for all...